Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 218,000 | 153,200 | 105,200 | 47,700 | 229,100 |
| Depreciation Amortization | 56,500 | 41,100 | 27,700 | 14,000 | 58,700 |
| Income taxes - deferred | -11,200 | -6,800 | -4,200 | 2,700 | -10,000 |
| Accounts receivable | -34,200 | -31,800 | -41,100 | -15,600 | -51,600 |
| Other Working Capital | -1,100 | -27,100 | -55,100 | -36,600 | -54,100 |
| Other Operating Activity | 23,400 | 28,800 | 28,500 | 800 | -6,800 |
| Operating Cash Flow | $251,400 | $157,400 | $61,000 | $13,000 | $165,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -400 | -300 | -700 | -600 | 9,700 |
| PPE Investments | -55,200 | -35,000 | -20,100 | -5,900 | 33,900 |
| Purchase Of Investment | -6,900 | 0 | -1,200 | 1,200 | -5,800 |
| Sale Of Investment | 2,200 | -1,900 | N/A | N/A | 2,300 |
| Purchase Sale Intangibles | -1,200 | -1,200 | -1,200 | -1,200 | N/A |
| Other Investing Activity | -1,200 | -1,200 | -1,200 | -1,200 | 0 |
| Investing Cash Flow | $-61,500 | $-38,400 | $-23,200 | $-6,500 | $40,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 254,400 | 216,800 | 188,200 | 104,500 | 129,300 |
| Debt Repayment | -302,800 | -207,600 | -99,400 | -64,400 | -213,900 |
| Common Stock Issued | 92,100 | 73,800 | 53,400 | 33,300 | 66,700 |
| Common Stock Repurchased | -200,000 | -200,000 | -199,300 | -98,000 | -95,500 |
| Other Financing Activity | 52,400 | 39,700 | 36,400 | 18,200 | 21,600 |
| Financing Cash Flow | $-103,900 | $-77,300 | $-20,700 | $-6,400 | $-91,800 |
| Exchange Rate Effect | -24,000 | -14,800 | -30,900 | -13,000 | 1,800 |
| Beginning Cash Position | 334,100 | 334,100 | 334,100 | 334,100 | 218,700 |
| End Cash Position | 396,100 | 361,000 | 320,300 | 321,200 | 334,100 |
| Net Cash Flow | $62,000 | $26,900 | $-13,800 | $-12,900 | $115,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 251,400 | 157,400 | 61,000 | 13,000 | 165,300 |
| Capital Expenditure | -61,800 | -40,100 | -23,700 | -8,000 | -64,000 |
| Free Cash Flow | 189,600 | 117,300 | 37,300 | 5,000 | 101,300 |